156 related articles for article (PubMed ID: 17290584)
1. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
[TBL] [Abstract][Full Text] [Related]
2. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
5. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
6. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
[TBL] [Abstract][Full Text] [Related]
7. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
[TBL] [Abstract][Full Text] [Related]
8. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
[TBL] [Abstract][Full Text] [Related]
9. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
[TBL] [Abstract][Full Text] [Related]
10. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
Beaman MH; Remington JS; Meyer DJ
Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
[TBL] [Abstract][Full Text] [Related]
12. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.
Hoffmann-Fezer G; Gall C; Zengerle U; Kranz B; Thierfelder S
Blood; 1993 Jun; 81(12):3440-8. PubMed ID: 8099506
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
14. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
[TBL] [Abstract][Full Text] [Related]
15. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
17. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
18. Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells.
Gysemans C; Waer M; Laureys J; Depovere J; Pipeleers D; Bouillon R; Mathieu C
Clin Exp Immunol; 2000 Sep; 121(3):557-65. PubMed ID: 10971525
[TBL] [Abstract][Full Text] [Related]
19. Human peripheral blood lymphocyte-reconstituted, severe combined immunodeficient mice as a model for porcine islet xenograft rejection in humans.
Shiroki R; Nazirrudin B; Hoshinaga K; Naide Y; Scharp DW; Mohanakumar T
Artif Organs; 1996 Aug; 20(8):878-82. PubMed ID: 8853799
[TBL] [Abstract][Full Text] [Related]
20. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]